106 related articles for article (PubMed ID: 25521737)
41. Recent advances in our understanding of the biology and pathogenesis of gastric mucosa-associated lymphoid tissue (malt) lymphoma.
Du MQ; Isaacson PG
Forum (Genova); 1998; 8(2):162-73. PubMed ID: 9666052
[TBL] [Abstract][Full Text] [Related]
42. [Malignant lymphoma and Helicobacter pylori infection].
Bamba T; Inoue T; Koyama S
Nihon Rinsho; 2000 Mar; 58(3):567-72. PubMed ID: 10741127
[TBL] [Abstract][Full Text] [Related]
43. MALT lymphomas: pathogenesis can drive treatment.
Bertoni F; Coiffier B; Salles G; Stathis A; Traverse-Glehen A; Thieblemont C; Zucca E
Oncology (Williston Park); 2011 Nov; 25(12):1134-42, 1147. PubMed ID: 22229204
[TBL] [Abstract][Full Text] [Related]
44. [Gastric relapse of stage I ocular adnexal mucosa-associated lymphoid tissue lymphoma].
Sato T; Takimoto R; Iyama S; Ono K; Tanaka S; Araki N; Nishiie K; Murase K; Sato Y; Kobune M; Matsunaga T; Kato J; Niitsu Y
Rinsho Ketsueki; 2007 Jan; 48(1):56-60. PubMed ID: 17313077
[TBL] [Abstract][Full Text] [Related]
45. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
[TBL] [Abstract][Full Text] [Related]
46. MALT Lymphoma, Stress Ulcer and Cholinergic Nerves from the Viewpoint of Bilateral and Unilateral Truncal Vagotomy and Substance P.
Kodama Y; Sasaki K; Murasato F; Overby A; Takahashi S; Murayama SY; Matsui H; Nakamura M
Curr Pharm Des; 2018; 24(18):1961-1965. PubMed ID: 29766790
[TBL] [Abstract][Full Text] [Related]
47. Endoscopic and histologic analysis of gastric mucosa-associated lymphoid tissue in children with Helicobacter pylori infection.
Yang HR; Choi HS; Paik JH; Lee HS
J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):298-304. PubMed ID: 23974061
[TBL] [Abstract][Full Text] [Related]
48. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up.
Montalban C; Santon A; Boixeda D; Redondo C; Alvarez I; Calleja JL; de Argila CM; Bellas C
Haematologica; 2001 Jun; 86(6):609-17. PubMed ID: 11418369
[TBL] [Abstract][Full Text] [Related]
49. A Gain-Of-Function Mutation in the Plcg2 Gene Protects Mice from Helicobacter felis-Induced Gastric MALT Lymphoma.
Gossmann J; Stolte M; Lohoff M; Yu P; Moll R; Finkernagel F; Garn H; Brendel C; Bittner A; Neubauer A; Huynh MQ
PLoS One; 2016; 11(3):e0150411. PubMed ID: 26966907
[TBL] [Abstract][Full Text] [Related]
50. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
Matsumoto K; Nakamura T; Sakai K; Nakamura T
Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008
[TBL] [Abstract][Full Text] [Related]
51. Expression of hepatocyte growth factor and c-met receptor in gastric mucosa during gastric ulcer healing.
Hori K; Shiota G; Kawasaki H
Scand J Gastroenterol; 2000 Jan; 35(1):23-31. PubMed ID: 10672830
[TBL] [Abstract][Full Text] [Related]
52. New pharmaceutical treatment of gastric MALT lymphoma: anti-angiogenesis treatment using VEGF receptor antibodies and celecoxib.
Nakamura M; Takahashi T; Matsui H; Takahashi S; Murayama SY; Suzuki H; Tsuchimoto K
Curr Pharm Des; 2014; 20(7):1097-103. PubMed ID: 23782142
[TBL] [Abstract][Full Text] [Related]
53. Abnormality of the hepatocyte growth factor/MET pathway in pulmonary adenocarcinogenesis.
Tachibana K; Minami Y; Shiba-Ishii A; Kano J; Nakazato Y; Sato Y; Goya T; Noguchi M
Lung Cancer; 2012 Feb; 75(2):181-8. PubMed ID: 21872356
[TBL] [Abstract][Full Text] [Related]
54. APRIL-producing eosinophils are involved in gastric MALT lymphomagenesis induced by Helicobacter sp infection.
Blosse A; Peru S; Levy M; Marteyn B; Floch P; Sifré E; Giese A; Prochazkova-Carlotti M; Azzi Martin L; Dubus P; Mégraud F; Ruskone Fournestraux A; Fabiani B; Copie Bergman C; Robe C; Hahne M; Huard B; Lehours P
Sci Rep; 2020 Sep; 10(1):14858. PubMed ID: 32908188
[TBL] [Abstract][Full Text] [Related]
55. Anti-CXCL13 antibody can inhibit the formation of gastric lymphoid follicles induced by Helicobacter infection.
Yamamoto K; Nishiumi S; Yang L; Klimatcheva E; Pandina T; Takahashi S; Matsui H; Nakamura M; Zauderer M; Yoshida M; Azuma T
Mucosal Immunol; 2014 Sep; 7(5):1244-54. PubMed ID: 24646940
[TBL] [Abstract][Full Text] [Related]
56. Follicular dendritic cells catalyze hepatocyte growth factor (HGF) activation in the germinal center microenvironment by secreting the serine protease HGF activator.
Tjin EP; Bende RJ; Derksen PW; van Huijstee AP; Kataoka H; Spaargaren M; Pals ST
J Immunol; 2005 Sep; 175(5):2807-13. PubMed ID: 16116166
[TBL] [Abstract][Full Text] [Related]
57. The role of hepatocyte growth factor and its receptor c-Met in multiple myeloma and other blood malignancies.
Børset M; Seidel C; Hjorth-Hansen H; Waage A; Sundan A
Leuk Lymphoma; 1999 Jan; 32(3-4):249-56. PubMed ID: 10037022
[TBL] [Abstract][Full Text] [Related]
58. The HGF/MET pathway as target for the treatment of multiple myeloma and B-cell lymphomas.
Mahtouk K; Tjin EP; Spaargaren M; Pals ST
Biochim Biophys Acta; 2010 Dec; 1806(2):208-19. PubMed ID: 20655987
[TBL] [Abstract][Full Text] [Related]
59. Significance of Cholinergic and Peptidergic Nerves in Stress-Induced Ulcer and MALT Lymphoma Formation.
Nakamura M; Overby A; Uehara A; Oda M; Takahashi S; Murayama SY; Matsui H
Curr Pharm Des; 2017 Oct; 23(27):3993-3996. PubMed ID: 28190393
[TBL] [Abstract][Full Text] [Related]
60. MALT lymphoma: from morphology to molecules.
Isaacson PG; Du MQ
Nat Rev Cancer; 2004 Aug; 4(8):644-53. PubMed ID: 15286744
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
